Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 6,229 | 1,402 | 10,632 | 13,817 | 158,569 |
| Gross Profit | 6,229 | 1,402 | 10,632 | 13,817 | 158,569 |
| Operating Expenses | 59,647 | 62,841 | 53,723 | 41,117 | 47,329 |
| Operating Income | -53,418 | -61,439 | -43,091 | -27,300 | 111,240 |
| Other Income | 3,415 | 3,505 | 3,466 | 3,817 | 2,917 |
| Pre-tax Income | -50,003 | -57,934 | -39,625 | -23,483 | 114,157 |
| Income Tax | N/A | N/A | -1,278 | 0 | 1,278 |
| Net Income Continuous | -50,003 | -57,934 | -38,347 | -23,483 | 112,879 |
| Net Income | $-50,003 | $-57,934 | $-38,347 | $-23,483 | $112,879 |
| EPS Basic Total Ops | -0.79 | -1.02 | -0.65 | -0.40 | 1.95 |
| EPS Basic Continuous Ops | -0.79 | -1.01 | -0.65 | -0.40 | 1.95 |
| EPS Diluted Total Ops | -0.79 | -0.97 | -0.65 | -0.40 | 1.90 |
| EPS Diluted Continuous Ops | -0.79 | -0.96 | -0.65 | -0.40 | 1.90 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.97 | -0.65 | -0.40 | 1.90 |
| EBITDA(a) | $-53,344 | $-61,585 | $-43,264 | $-26,327 | $111,223 |